Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(6 sites)
Israel
Emek Medical Center, Afula Barzilai Medical Center, Ashkelon Carmel Medical Center, Haifa Rambam Health Campus, Haifa Meir Medical Center, Kfar Saba